Philippe Moreau Selected Research

Radioimmunotherapy

1/2017	Consolidation anti-CD22 fractionated radioimmunotherapy with 90Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial.
9/2013	213Bi radioimmunotherapy with an anti-mCD138 monoclonal antibody in a murine model of multiple myeloma.
6/2012	Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Moreau Research Topics

Disease

335	Multiple Myeloma 05/2024 - 01/2002
73	Neoplasms (Cancer) 04/2024 - 01/2003
39	Disease Progression 03/2024 - 11/2005
23	Infections 01/2024 - 12/2005
19	Thrombocytopenia (Thrombopenia) 10/2023 - 04/2013
19	Neutropenia 10/2023 - 08/2009
18	Peripheral Nervous System Diseases (PNS Diseases) 02/2021 - 08/2009
17	Residual Neoplasm 03/2024 - 11/2012
12	Chromosome Aberrations (Chromosome Abnormalities) 03/2024 - 10/2010
11	Pneumonia (Pneumonitis) 10/2023 - 10/2013
9	Inflammation (Inflammations) 04/2024 - 02/2003
9	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 12/2004
8	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 01/2010
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2023 - 11/2005
8	Hypoxia (Hypoxemia) 08/2023 - 04/2007
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2003
8	Melanoma (Melanoma, Malignant) 01/2018 - 10/2003
7	Malaria 01/2022 - 06/2013
7	Lymphopenia (Lymphocytopenia) 11/2021 - 10/2014
6	Sepsis (Septicemia) 10/2023 - 12/2009
6	Lymphoma (Lymphomas) 10/2021 - 03/2002
6	Fatigue 01/2020 - 10/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 03/2002
6	Virus Diseases (Viral Diseases) 01/2017 - 01/2003
5	Vomiting 01/2023 - 03/2012
5	Immunoglobulin Light-chain Amyloidosis 10/2020 - 11/2004
5	Smoldering Multiple Myeloma 05/2020 - 10/2017
5	Choriocarcinoma 10/2019 - 11/2003
4	Septic Shock (Toxic Shock Syndrome) 10/2023 - 10/2017
4	Cytokine Release Syndrome 03/2023 - 01/2023
4	Nausea 01/2023 - 03/2012
4	Hypertension (High Blood Pressure) 10/2021 - 01/2016
4	Monoclonal Gammopathy of Undetermined Significance 01/2021 - 01/2017
4	Pain (Aches) 01/2021 - 04/2008
4	Leukemia 01/2019 - 07/2012
4	Anemia 01/2019 - 10/2016
3	Glioma (Gliomas) 01/2023 - 02/2013
3	Plasmacytoma 11/2022 - 01/2013
3	Bone Diseases (Bone Disease) 01/2022 - 03/2014
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 01/2019
3	Diarrhea 08/2020 - 03/2017
3	Febrile Neutropenia 05/2020 - 04/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2019 - 09/2014

Drug/Important Bio-Agent (IBA)

151	Dexamethasone (Maxidex)FDA LinkGeneric 05/2024 - 11/2006
82	Bortezomib (Velcade)FDA Link 05/2024 - 11/2006
77	Lenalidomide (CC 5013)FDA Link 02/2024 - 05/2008
47	HLA-G Antigens (HLA G)IBA 08/2023 - 01/2003
45	carfilzomibIBA 03/2024 - 04/2014
40	Proteasome InhibitorsIBA 12/2023 - 08/2012
39	daratumumabIBA 01/2024 - 06/2016
35	pomalidomideIBA 03/2024 - 03/2013
29	Monoclonal AntibodiesIBA 03/2024 - 09/2007
28	Thalidomide (Thalomid)FDA Link 01/2023 - 01/2002
25	isatuximabIBA 03/2024 - 12/2019
22	ixazomibIBA 02/2024 - 08/2014
21	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 02/2002
20	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2005
16	Immunomodulating AgentsIBA 03/2024 - 07/2013
11	PanobinostatIBA 01/2021 - 07/2013
11	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021 - 11/2005
9	B-Cell Maturation AntigenIBA 04/2024 - 01/2020
8	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 12/2014
8	elotuzumabIBA 01/2023 - 06/2012
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2021 - 02/2015
7	selinexorIBA 05/2024 - 01/2019
7	venetoclaxIBA 11/2021 - 04/2015
6	AntibodiesIBA 12/2023 - 01/2021
6	Chimeric Antigen ReceptorsIBA 03/2023 - 12/2019
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023 - 11/2009
6	Prednisone (Sone)FDA LinkGeneric 01/2019 - 11/2008
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 04/2024 - 01/2021
5	Bispecific AntibodiesIBA 01/2024 - 01/2022
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
5	CytokinesIBA 01/2021 - 10/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2009
4	idecabtagene vicleucelIBA 04/2024 - 01/2021
4	AntigensIBA 03/2024 - 11/2005
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2014
4	Alkylating AgentsIBA 01/2023 - 02/2010
4	Immunoglobulin G (IgG)IBA 01/2022 - 09/2013
4	Histone Deacetylase InhibitorsIBA 01/2018 - 07/2013
4	3' Untranslated Regions (3' UTR)IBA 01/2017 - 06/2013
4	Messenger RNA (mRNA)IBA 09/2016 - 10/2005
3	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 08/2023 - 09/2008
3	dabrafenibIBA 01/2023 - 07/2020
3	trametinibIBA 01/2023 - 07/2020
3	VaccinesIBA 01/2023 - 12/2021
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2015

Therapy/Procedure

141	Therapeutics 05/2024 - 01/2002
61	Stem Cell Transplantation 01/2023 - 02/2002
24	Transplantation 12/2023 - 05/2008
22	Drug Therapy (Chemotherapy) 12/2021 - 09/2002
9	Hematopoietic Stem Cell Transplantation 05/2022 - 12/2004
6	Immunotherapy 03/2024 - 09/2016
5	Autologous Transplantation 01/2014 - 11/2008
4	Subcutaneous Injections 11/2022 - 12/2008
4	Intravenous Administration 10/2022 - 12/2008
3	Salvage Therapy 01/2023 - 12/2004
3	Cell Transplantation 01/2020 - 02/2015